188 related articles for article (PubMed ID: 31848373)
1. Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
Kim YJ; Park SJ; Maeng KJ; Lee SC; Lee CS
Sci Rep; 2019 Dec; 9(1):19235. PubMed ID: 31848373
[TBL] [Abstract][Full Text] [Related]
2. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
[TBL] [Abstract][Full Text] [Related]
4. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
Zhan Z; Lin K; Wang T
BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Functional Analysis of
Mei S; Li Y; Kang X
Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
7. Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).
Luke JJ; Olson DJ; Allred JB; Strand CA; Bao R; Zha Y; Carll T; Labadie BW; Bastos BR; Butler MO; Hogg D; Munster PN; Schwartz GK
Clin Cancer Res; 2020 Feb; 26(4):804-811. PubMed ID: 31558480
[TBL] [Abstract][Full Text] [Related]
8. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based integrative analysis of methylome and transcriptome identifies novel prognostic DNA methylation signature in uveal melanoma.
Hou P; Bao S; Fan D; Yan C; Su J; Qu J; Zhou M
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33367533
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.
Lei P; Xue L; Wu Y; Zhong J
Bioengineered; 2022; 13(7-12):15033-15044. PubMed ID: 37105900
[TBL] [Abstract][Full Text] [Related]
11. Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma.
Orozco CA; Mejía-García A; Ramírez M; González J; Castro-Vega L; Kreider RB; Serrano S; Combita AL; Bonilla DA
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509183
[TBL] [Abstract][Full Text] [Related]
12. Metastatic uveal melanoma: biology and emerging treatments.
Woodman SE
Cancer J; 2012; 18(2):148-52. PubMed ID: 22453016
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
[TBL] [Abstract][Full Text] [Related]
15. The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma.
Venza M; Visalli M; Oteri R; Agliano F; Morabito S; Teti D; Venza I
Int Immunopharmacol; 2015 Sep; 28(1):313-21. PubMed ID: 26122536
[TBL] [Abstract][Full Text] [Related]
16. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma.
Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J
Front Immunol; 2022; 13():1026076. PubMed ID: 36311731
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of driver events in metastatic uveal melanoma.
Karlsson J; Nilsson LM; Mitra S; Alsén S; Shelke GV; Sah VR; Forsberg EMV; Stierner U; All-Eriksson C; Einarsdottir B; Jespersen H; Ny L; Lindnér P; Larsson E; Olofsson Bagge R; Nilsson JA
Nat Commun; 2020 Apr; 11(1):1894. PubMed ID: 32313009
[TBL] [Abstract][Full Text] [Related]
19. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
[TBL] [Abstract][Full Text] [Related]
20. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
